SOLARA.NS Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: February 24, 2026

Report Source: 2026 3rd Quarter Report

Solara Active Pharma Sciences Ltd

Solara Active Pharma Sciences Ltd. Stock Analysis SOLARA.NS

India Health Care Micro Cap Report:
Solara Active Pharma Sciences Ltd. engages in the manufacture and development of active pharmaceutical ingredient. The company is headquartered in Chennai, Tamil Nadu and currently employs 1,775 full-time employees. The company went IPO on 2018-06-27. The firm is engaged in the manufacturing and development of APIs and offers contract manufacturing and development services for global companies. Its commercial product category includes Albendazole, Aprepitant (Antiemetic), Colchicine, Citicoline Sodium, Disulfiram, Dolutegravir, Etomidate, Flucytosine, Ibuprofen Arginine, Lurasidone Hydrochloride, Rifaximin, Tioconazole, Zileuton and others. Its research and development (R&D) product category includes Brivaracetam, Flecainide Acetate, Naproxen Base, Obeticholic acid, Patiromer Sorbitex Calcium, Rotigotine, Safinamide, Sapropterin, Sugammadex, Tranexamic Acid, Sucroferric Oxyhydroxide and others. Its business is spread across 70 countries with operations in the key markets of North America, Europe, Japan, South Korea and the Middle East and North Africa. The company has one R&D center in Chennai.
Read More

Solara Active Pharma Sciences Ltd (SOLARA.NS) Chart

Key Statistics of Solara Active Pharma Sciences Ltd (SOLARA.NS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹502.00₹598.50

Today's Open

₹514.10

Volume

4.01M

P/E Ratio (TTM)

4,571.39

52 Week Range

₹422.00₹734.40

Market Cap

24.97B

Avg. Volume

113.32K

Dividend Yield

-

Financial Metrics & Statements of Solara Active Pharma Sciences Ltd (SOLARA.NS)

FAQ's for Solara Active Pharma Sciences Ltd (SOLARA.NS)

  • According to Musaffa’s Shariah screening methodology, Solara Active Pharma Sciences Ltd (SOLARA.NS) is currently classified as HALAL as of February 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.